期刊
ACS NANO
卷 6, 期 5, 页码 3670-3676出版社
AMER CHEMICAL SOC
DOI: 10.1021/nn301869z
关键词
-
类别
资金
- NCI NIH HHS [U54 CA151884, CA151884] Funding Source: Medline
- NIBIB NIH HHS [EB003647, K08 EB003647] Funding Source: Medline
With advances in aptamer selection technologies and nanomedicine, aptamer-functionalized nanoparticles are being explored as promising platforms for targeted therapeutic and diagnostic applications. In this Perspective, we outline recent progress in this field, as exemplified by Bamrungsap et al. in this issue of ACS Nano. Furthermore, we highlight the challenges and opportunities in translating current proof-of-concept designs into in vivo applications, with emphasis on the intrinsic properties of aptamers and their interplay with nanoparticles. With continuous efforts, we expect aptamer-functionalized nanoparticles to advance from preclinical into clinical development for further evaluation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据